As Grb2Y160E can promote phosphatase activity in the absence of Shp2 phosphorylation, this could lead to a proliferative outcome in cells through upregulation of the Erk1/2 pathway without the need for the elevated kinase activity often associated with cancer phenotypes. Here, MAPK3 is linked to cancer.